Infocom Corporation (Tokyo; Norihiro Takehara, president and CEO) today announced a strategic partnership with Docquity Holdings Pte. Ltd. (Singapore; Indranil Roychowdhury, CEO). Docquity Holdings (“Docquity”) operates the network platform for doctors “Docquity” in Southeast Asia.
Docquity owns and operates the Docquity network platform, which allows doctors to discuss clinical experiences and exchange opinions across six Southeast Asian countries, including Indonesia and the Philippines. The network boasts a high share of its market, with nearly half of the doctors practicing in these six countries using the platform.
Infocom is engaged in its Asia Healthcare Project, in its a three-year medium-term management program launched in fiscal year 2020. In this project Infocom plans to make strategic investments in promising startups, mainly in Southeast Asia, as well as to expand its own healthcare IT services in the region. As part of this project, Infocom began offering drug information system in Southeast Asia in April 2021.
The companies plan to integrate the drug information system developed by Infocom for Southeast Asia with the Docquity platform, allowing doctors on the Docquity platform to access the drug information system.
Infocom believes that this strategic partnership will allow the company to expand its service of drug information system in the emerging countries of Southeast Asia, while also improving the quality of the company’s service. Docquity Holdings will expand platform functions and acquire new users to the Docquity platform from this new partnership.
Docquity Holdings Pte. Ltd.
Founder & CEO: Indranil Roychowdhury
Established: February 2017
Head Office: Singapore
Locations: Indonesia, the Philippines, Thailand, Malaysia, Vietnam, Myanmar
Employees: Approx. 160
In parallel with rolling out its drug information system for medical institutions in the Philippines and other regions of Southeast Asia, Infocom will continue to build a strong partnership with Docquity, aiming to expand the company’s drug information system among individual medical practitioners, as well as to improve the quality of the system.